Difference between revisions of "User:Shawndouglas/sandbox/sublevel35"
From LIMSWiki
< User:Shawndouglas | sandbox
Jump to navigationJump to searchShawndouglas (talk | contribs)  | 
				Shawndouglas (talk | contribs)   | 
				||
| Line 28: | Line 28: | ||
===4.3 Web portals===  | ===4.3 Web portals===  | ||
====4.3.1 U.S.   | ====4.3.1 U.S. agency portals====  | ||
* [https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html Coronavirus Disease 2019 (COVID-19) - Information for Healthcare Professionals] (CDC)  | * [https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html Coronavirus Disease 2019 (COVID-19) - Information for Healthcare Professionals] (CDC)  | ||
| Line 35: | Line 35: | ||
* [https://www.fema.gov/coronavirus Coronavirus (COVID-19) Response] (FEMA)  | * [https://www.fema.gov/coronavirus Coronavirus (COVID-19) Response] (FEMA)  | ||
====4.3.2 U.S. state  | ====4.3.2 U.S. state and territory portals====  | ||
* [https://  | * [https://governor.alabama.gov/newsroom/covid-19/ Alabama]  | ||
* [https://www.health.state.mn.us/diseases/coronavirus/  | * [http://dhss.alaska.gov/dph/Epi/id/Pages/COVID-19/default.aspx Alaska]  | ||
* [https://az.gov/government-0 Arizona]  | |||
* [https://govstatus.egov.com/ar-covid-19 Arkansas]  | |||
* [https://covid19.ca.gov/ California]  | |||
* [https://covid19.colorado.gov/ Colorado]  | |||
* [https://portal.ct.gov/coronavirus Connecticut]  | |||
* [https://coronavirus.delaware.gov/ Delaware]  | |||
* [https://coronavirus.dc.gov/ District of Columbia]  | |||
* [https://floridahealthcovid19.gov/ Florida]  | |||
* [https://georgia.gov/covid-19-state-services-georgia Georgia]  | |||
* [https://hawaiicovid19.com/ Hawaii]  | |||
* [https://coronavirus.idaho.gov/ Idaho]  | |||
* [https://coronavirus.illinois.gov/ Illinois]  | |||
* [https://coronavirus.in.gov/ Indiana]  | |||
* [https://coronavirus.iowa.gov/ Iowa]  | |||
* [https://govstatus.egov.com/coronavirus Kansas]  | |||
* [https://govstatus.egov.com/kycovid19 Kentucky]  | |||
* [https://gov.louisiana.gov/coronavirus/ Louisiana]  | |||
* [https://www.maine.gov/governor/mills/covid-19 Maine]  | |||
* [https://coronavirus.maryland.gov/ Maryland]  | |||
* [https://www.mass.gov/info-details/covid-19-updates-and-information Massachusetts]  | |||
* [https://www.michigan.gov/coronavirus/ Michigan]  | |||
* [https://www.health.state.mn.us/diseases/coronavirus/index.html Minnesota]  | |||
* [https://www.coronavirus.ms.gov/ Mississippi]  | |||
* [https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/ Missouri]  | * [https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/ Missouri]  | ||
* [https://covid19.mt.gov/ Montana]  | |||
* [http://dhhs.ne.gov/Pages/Coronavirus.aspx Nebraska]  | |||
* [https://nvhealthresponse.nv.gov/ Nevada]  | |||
* [https://www.nh.gov/covid19/ New Hampshire]  | * [https://www.nh.gov/covid19/ New Hampshire]  | ||
* [https://covid19.nj.gov/ New Jersey]  | |||
* [https://www.newmexico.gov/ New Mexico]  | |||
* [https://coronavirus.health.ny.gov/home New York]  | * [https://coronavirus.health.ny.gov/home New York]  | ||
* [https://www.  | * [https://www.ncdhhs.gov/divisions/public-health/coronavirus-disease-2019-covid-19-response-north-carolina North Carolina]  | ||
* [https://ndresponse.gov/covid-19-resources North Dakota]  | |||
* [https://coronavirus.ohio.gov/wps/portal/gov/covid-19/home Ohio]  | |||
* [https://coronavirus.health.ok.gov/ Oklahoma]  | |||
* [https://govstatus.egov.com/or-covid-19 Oregon]  | |||
* [https://www.pa.gov/guides/responding-to-covid-19/ Pennsylvania]  | |||
* [https://health.ri.gov/covid/ Rhode Island]  | |||
* [https://www.scdhec.gov/infectious-diseases/viruses/coronavirus-disease-2019-covid-19 South Carolina]  | |||
* [https://covid.sd.gov/ South Dakota]  | |||
* [https://www.tn.gov/governor/covid-19.html Tennessee]  | |||
* [https://texas.gov/#covid19 Texas]  | |||
* [https://coronavirus.utah.gov/ Utah]  | |||
* [https://www.healthvermont.gov/response/infectious-disease/2019-novel-coronavirus Vermont]  | |||
* [https://www.virginia.gov/coronavirus/ Virginia]  | |||
* [https://coronavirus.wa.gov/ Washington]  | |||
* [https://dhhr.wv.gov/COVID-19/Pages/default.aspx West Virginia]  | |||
* [https://www.dhs.wisconsin.gov/covid-19/index.htm Wisconsin]  | |||
* [https://covid19.wyo.gov/ Wyoming]  | |||
'''U.S. territories'''  | |||
* [https://www.americansamoa.gov/ American Samoa]  | |||
* [https://ghs.guam.gov/coronavirus-covid-19 Guam]  | |||
* [https://gov.mp/ Northern Mariana Islands]  | |||
* [https://www.facebook.com/puertoricomedicaltaskforcecovid19/ Puerto Rico]  | |||
* [https://doh.vi.gov/covid19usvi Virgin Islands]  | |||
====4.3.3 Other national and multinational portals====  | ====4.3.3 Other national and multinational portals====  | ||
Revision as of 18:01, 2 April 2020
4. Final thoughts and additional resources
4.1 Final thoughts
4.2 Key guidance documents
- Centers for Disease Control and Prevention (24 March 2020). "Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html.
 
- Centers for Disease Control and Prevention (24 March 2020). "Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html.
 
- Centers for Disease Control and Prevention (31 March 2020). "Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html.
 
- Occupational Safety and Health Administration (March 2020). "Guidance on Preparing Workplaces for COVID-19" (PDF). OSHA 3990-03 2020. Occupational Safety and Health Administration. https://www.osha.gov/Publications/OSHA3990.pdf.
 
- Public Health England (28 March 2020). "COVID-19: Guidance for sampling and for diagnostic laboratories". U.K Government. https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories.
 
- U.S. Food and Drug Administration (25 March 2020). "Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency". FDA-2020-D-1138-0013. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health.
 
- U.S. Food and Drug Administration (30 March 2020). "Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency". FDA-2020-D-1138-0023. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health.
 
- U.S. Food and Drug Administration (16 March 2020). "Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency". FDA-2020-D-0987-0012. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency.
 
- World Health Organization, et al. (19 March 2020). "Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 19 March 2020". WHO/WPE/GIH/2020.2. World Health Organization. https://apps.who.int/iris/handle/10665/331500.
 
- World Health Organization, et al. (19 March 2020). "Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020". WHO/COVID-19/laboratory/2020.5. World Health Organization. https://apps.who.int/iris/handle/10665/331501.
 
4.3 Web portals
4.3.1 U.S. agency portals
- Coronavirus Disease 2019 (COVID-19) - Information for Healthcare Professionals (CDC)
 - Coronavirus Disease 2019 (COVID-19) - Information for Laboratories (CDC)
 - COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders (FDA)
 - Coronavirus (COVID-19) Response (FEMA)
 
4.3.2 U.S. state and territory portals
- Alabama
 - Alaska
 - Arizona
 - Arkansas
 - California
 - Colorado
 - Connecticut
 - Delaware
 - District of Columbia
 - Florida
 - Georgia
 - Hawaii
 - Idaho
 - Illinois
 - Indiana
 - Iowa
 - Kansas
 - Kentucky
 - Louisiana
 - Maine
 - Maryland
 - Massachusetts
 - Michigan
 - Minnesota
 - Mississippi
 - Missouri
 - Montana
 - Nebraska
 - Nevada
 - New Hampshire
 - New Jersey
 - New Mexico
 - New York
 - North Carolina
 - North Dakota
 - Ohio
 - Oklahoma
 - Oregon
 - Pennsylvania
 - Rhode Island
 - South Carolina
 - South Dakota
 - Tennessee
 - Texas
 - Utah
 - Vermont
 - Virginia
 - Washington
 - West Virginia
 - Wisconsin
 - Wyoming
 
U.S. territories
4.3.3 Other national and multinational portals
- Coronavirus - COVID-19 (ECDC)
 - Coronavirus disease (COVID-19) (Government of Canada)
 







